Folixapure
Folixapure is an FDA drug label for the active ingredient FOLIC ACID, VITAMIN D3 manufactured by PureTek Corporation administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20230111.
Generic: FOLIC ACID, VITAMIN D3
Manufacturer: PureTek Corporation
Product Type: HUMAN PRESCRIPTION DRUG
Route: ORAL
Dosage Form:
NDC: 59088-163
Application:
Effective: 20230111
Indications & Usage
INDICATIONS AND DOSAGE Folixapure™ is indicated for dietary management of patients with unique nutritional needs requiring increased folate levels and Vitamin D supplementation. Folixapure™ can be taken by women of childbearing age, pregnant women, and lactating and nonlactating mothers.
Dosage & Administration
DOSAGE AND ADMINISTRATION Take one tablet daily or as directed by a healthcare practitioner.
Contraindications
CONTRAINDICATIONS This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. Folixapure™ is contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D, and hypervitaminosis D.
Warnings
Not available.
Adverse Reactions
ADVERSE REACTIONS Allergic sensitization has been reported following both oral and parenteral administration of folic acid. You should call your doctor for medical advice about serious adverse events. To report adverse side effects or to obtain product information, contact PureTek Corporation, at 1-877-921-7873.
More from same ingredient
DermacinRx Purefoltin
PureTek Corporation
Dotremin
PureTek Corporation
Folditam
PureTek Corporation
Foltamin
PureTek Corporation
Foltrexyl
PureTek Corporation